Related Experiment Videos
Single cell gene expression profiling in Alzheimer's disease.
Stephen D Ginsberg1, Shaoli Che, Scott E Counts
1Center for Dementia Research, Nathan Kline Institute, Orangeburg, NY 10962, USA. ginsberg@nki.rfmh.org
Summary
Microarray techniques reveal molecular fingerprints of vulnerable neurons in Alzheimer's disease (AD). Gene expression analysis in AD brains identifies shared alterations, aiding in understanding disease pathogenesis and developing targeted therapies.
Area of Science:
- Neuroscience
- Molecular Biology
- Genomics
Background:
- Alzheimer's disease (AD) and related neurodegenerative disorders present complex molecular pathogenesis.
- Understanding gene expression in specific neuronal populations is crucial for disease research.
Purpose of the Study:
- To develop and implement microarray techniques for quantifying gene expression in specific cell types.
- To create molecular fingerprints of vulnerable neurons in AD and related disorders.
- To identify molecular targets for therapeutic interventions.
Main Methods:
- Utilized microarray techniques to simultaneously quantify thousands of transcripts in brain tissue samples.
- Employed single-cell and population cell RNA analysis combined with real-time quantitative polymerase chain reaction (qPCR).
- Analyzed postmortem human brain tissues from normal controls and AD patients, focusing on the hippocampal formation and neocortex.
Main Results:
- Identified molecular fingerprints of vulnerable neuronal populations in AD.
- Revealed selectively vulnerable cell types in AD brains share common pathogenetic alterations in transcript classes.
- Observed alterations in markers of glutamatergic neurotransmission, synaptic function, protein kinases/phosphatases, and neurotrophins.
Conclusions:
- Gene expression profiling of vulnerable regions and neurons provides insights into neurodegenerative disease pathogenesis.
- Findings aid in identifying rational targets for pharmacotherapeutic interventions in late-onset neurodegenerative disorders like mild cognitive impairment (MCI) and AD.